The aim of this protocol is to support the conduct of entomological comparative efficacy assessments for vector control products and the associated non-inferiority analysis. This evidence is used to inform discussions within the guidelines development context as to whether a new vector control product should be considered as covered by one or more existing WHO recommendations or not. Alternatively, the evidence may inform the extension of an existing WHO recommendation or the development of a new one, provided that non-inferiority is demonstrated.

On 30 October–1 November 2023, the WHO Malaria Policy Advisory Group (MPAG) convened to review updates and progress, and to provide guidance on thematic areas of work by the Global Malaria Programme. The meeting focused on the following topics: the Global Malaria Programme operational strategy 2024–2030; malaria vaccines R21/Matrix-M and RTS,S/AS01, the Malaria Vaccine Implementation Programme (MVIP) and status of malaria vaccine roll-out; guiding principles for prioritizing malaria interventions in resource-constrained settings to achieve maximum impact; progress and challenges on subnational tailoring of interventions; comparative effectiveness in the context of the arrival of new vector control products; the “High burden to high impact” (HBHI) approach; the WHO guidelines for malaria; antimalarial drug resistance in Africa; and the Mekong Malaria Elimination programme.

This meeting report describes the discussion and outcomes of the technical consultation on the value of non-inferiority assessments within the vector control evaluation process, for interventions that fall within an established intervention class. The discussion was based on pilot trials assessing non-inferiority of pyrethroid-PBO nets against malaria. Objectives of the meeting included determining the value, and challenges associated with using non-inferiority assessments and considerations of how these evaluations could be implemented within the existing framework of the WHO vector control evaluation process.

On 18–20 April 2023, the WHO Malaria Policy Advisory Group (MPAG) convened to review updates and progress, and to provide guidance on thematic areas of work by the Global Malaria Programme. The meeting focused on the following topics: 1) the RBM Partnership to End Malaria evaluation of the “High burden to high impact” (HBHI) approach; 2) updates on the vector control, treatment and diagnostic recommendations in the WHO guidelines for malaria; 3) revisiting comparative effectiveness in the context of the arrival of new vector control products; 4) an update on certification of malaria elimination and the E-2025 Global Forum; 5) an update on the RTS,S/AS01 Malaria Vaccine Implementation Programme and WHO evidence review for the R21/Matrix-M vaccine; 6) an update on the work areas of the Strategic Information for Response Unit; 7) a report from the technical consultation on the effectiveness of rectal artesunate (RAS) and field implementation manual; 8) a report from the technical consultation on community-based delivery of intermittent preventive treatment of malaria in pregnancy (IPTp); 9) an update on the WHO/TDR field implementation manual for seasonal malaria chemoprevention (SMC); 10) an update on the Anopheles stephensi regional strategy; 11) an update on histidine-rich protein 2 (HRP2) gene deletions and global response plan; and 12) an update on antimalarial drug resistance in Africa.

Each year, WHO’s World malaria report offers in-depth information on the latest trends in malaria control and elimination at global, regional and country levels. The report highlights progress towards global targets and describes opportunities and challenges for curbing and eliminating the disease. This year’s report includes three new sections on: (1) global and regional initiatives launched in 2021 and 2022; (2) global malaria surveillance and country-level case studies on surveillance systems assessments; and (3) research and development. The report also includes an expanded section on threats to malaria control, with a focus on the declining effectiveness of insecticide-treated mosquito nets.

The public has a great desire for products that prevent the annoyance of biting insects and ticks, but that desire does not always translate into sensible use of those products. Insect Repellents Handbook, Second Edition summarizes evidence-based information on insect repellents to inform decisions by those involved with insect repellent research, development, and use. This authoritative, single-source reference makes it possible for you to quickly gain a working level of expertise about insect repellents, without having to search through the scattered literature. The previous edition was the first comprehensive volume on this subject and quickly became the definitive reference on insect repellents. This second edition reflects the current state of insect repellent science, covers the processes involved in the development and testing of new active ingredients and formulations, and discusses the practical uses of repellents. The book includes thought-provoking discussions on how repellents work, their neuromolecular basis of action, and whether green chemistry can provide effective repellents. It also supplies an in-depth understanding of the development of repellents including testing methods, review of active ingredients, and the use of chemical mixtures as repellents. It provides science-backed chapters on repellent use including best practices for use of personal protection products, criteria for repellent use, and insect repellents for other potential use.

- Includes new chapters to assist your care of specific populations such as those engaging in ecotourism or military travel, as well as the VIP traveler. A new chapter on pre-travel considerations for non-vaccine preventable travel infections has also been added. - Provides new information on new influenza and shingles vaccines, microbiome and drug resistance, Zika and the pregnant or breastfeeding traveler, the Viagra effect and increase in STIs, refugees and immigrants, and much more. - Covers new methods of prevention of dengue virus, Zika virus, chikungunya virus, Middle Eastern respiratory syndrome, sleeping sickness, and avian flu. - New illustrations and numerous new tables and boxes provide visual guidance and make reference quick and easy. - Helps you prepare for the travel medicine examination with convenient cross references to the ISTM "body of knowledge" in specific chapters and/or passages in the book. - Keeps you updated on remote destinations and the unique perils they present.

Drawing together information previously found only in articles, reviews, symposia proceedings, commercial literature, and medical entomology texts, Insect Repellents: Principles, Methods, and Uses is a one-volume source on the development, evaluation, and use of repellents. It provides a thoughtful analysis of old and new information, from t